Deficient Type I Protein Kinase A Isozyme Activity in Systemic Lupus Erythematosus T Lymphocytes: II. Abnormal Isozyme Kinetics

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2690-2698

  Kammer, Gary M ^a   Khan, Islam U ^a   Kammer, Jeffrey A ^a   Olorenshaw, Irene ^a   Mathis, Danielle ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOENZYME;

ADULT; AGED; ARTICLE; CHROMATOGRAPHY; ENZYME ACTIVATION; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; KINETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; AGED; CHROMATOGRAPHY; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOBLOTTING; ISOENZYMES; KINETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0030587119     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Kammer, G. M., and R. L. Stein. 1990. T lymphocyte immune dysfunctions in systemic lupus erythematosus. J. Lab. Clin. Med. 115:273.
2. Tsokos, G. C. 1992. Overview of cellular immune function in systemic lupus erythematosus. In Systemic Lupus Erythematosus, 2nd Ed. R. G. Lahita, ed. Churchill Livingstone, New York, p. 15.
3. Cohen, P. L. 1993. T- and B-cell abnormalities in systemic lupus. J. Invest. Dermatol. 100:69S.
4. Dayal, A. K., and G. M. Kammer. 1996. The T cell enigma in lupus. Arthritis Rheum. 39:23.
5. Kammer, G.M. 1983. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus: evidence for a disorder intrinsic to the T lymphocyte. J. Clin. Invest. 72:1686.
6. Mandler, R., R. E. Birch, S. Polmar, G. M. Kammer, and S. A. Rudolph. 1982. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 79:7542.
7. Kammer, G. M., R. E. Birch, and S. Polmar. 1983. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation. J. Immunol. 130:1706.
8. Kammer, G. M., and E. Mitchell. 1988. Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus: relationship to a defective cAMP pathway. Arthritis Rheum. 31:88.
9. Hasler, P., L. A. Schultz, and G. M. Kammer. 1990. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 87:1978.
10. Kammer, G. M., I. U. Khan, and C. J. Malemud. 1994. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J. Clin. Invest. 94:422.
11. Kammer, G. M., T. M. Haqqi, P. Hasler, and C. J. Malemud. 1993. The effect of circulating serum factors from patients with systemic lupus erythematosus on protein kinase A (PKA) activity and PKA-dependent protein phosphorylation in T lymphocytes. Clin. Immunol. Immunopathol. 67:8.
12. Krebs, E. G., and J. A. Beavo. 1979. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48:923.
13. Døskeland. S. O., and D. Øgreid. 1981. Binding proteins for cyclic AMP in mammalian tissues. Int. J. Biochem. 13:1.
14. Lohmann, S. M., and U. Walter. 1984. Regulation of me cellular and subcellular concentrations and distribution of cyclic nucleotide-dependent protein kinases. Adv. Cyclic Nucleotide Prot. Phosphoryl. Res. 18:63.
15. Taylor, S. S. 1989. cAMP-dependent protein kinase. Model for an enzyme family. J. Biol. Chem. 264:8443.
16. Francis, S. H., and J. D. Corbin. 1994. Structure and function of cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol. 56:237.
17. Beebe, S. J., O. Oyen, M. Sandberg, A. Froysa, V. Hansson, and T. Jahnsen. 1990. Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis-representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase. Mol. Endocrinol. 4:465.
18. Shuntoh, H., and R. A. Steinberg. 1991. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells. J. Cell. Physiol. 146:86.
19. Taskén, K., B. S. Skålhegg, R. Solberg, K. B. Andersson, S. S. Taylor, T. Lea, H. K. Blomhoff, T. Jahnsen, and V. Hansson. 1993. Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RIα-RIβ heterodimeric complexes. J. Biol. Chem. 268:21276.
20. Rangel-Aldao, R., and O. M. Rosen. 1977. Effect of cAMP and ATP on the reassociation of phosphorylated and nonphosphorylated subunits of the cAMP-dependent protein kinase from bovine cardiac muscle. J. Biol. Chem. 252:7140.
21. Connelly, P. A., T. G. Hastings, and E. M. Reimann. 1986. Identification of a ternary complex between cAMP and a trimeric form of cAMP-dependent protein kinase. J. Biol. Chem. 261:2325.
22. Showers, M. O., and R. A. Maurer. 1986. A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase. J. Biol. Chem. 261:16288.
23. Øgreid, D., and S. O. Døskeland. 1981. The kinetics of association of cyclic AMP to the two types of binding sites associated with protein kinase II from bovine myocardium. FEBS Lett. 129:287.
24. 3H]adenosine cyclic 3′,5′-phosphate bound to the regulatory moiety of protein kinase I by the catalytic subunit of the kinase. Biochemistry 22:1686.
25. Rannels, S. R., C. E. Cobb, L. R. Landiss, and J. D. Corbin. 1985. The regulatory subunit monomer of cAMP-dependent protein kinase retains the salient kinetic properties of the native dimeric subunit. J. Biol. Chem. 260:3423.
26. Su, Y., W. R. G. Dostmann, F. W. Herberg, K. Durick, N.-h. Xuong, L. T. Eyck, S. S. Taylor, and K. I. Varughese. 1995. Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains. Science 269:807.
27. Corbin, J. D., P. H. Sugden, L. West, D. A. Flockhart, T. M. Lincoln, and D. McCarthy. 1978. Studies on the properties and mode of action of the purified regulatory subunit of bovine heart adenosine 3′:5′-monophosphate-dependent protein kinase. J. Biol. Chem. 253:3997.
28. Tan, E. M., A. S. Cohen, F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 15:1271.
29. Bombardier, C., D. D. Gladman, M. B. Urowitz, D. Caron, C. H. Chang, and Committee on Prognosis Studies in SLE. 1992. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 35:630.
30. Døskeland, S. O., and D. Øgreid. 1988. Ammonium sulfate precipitation assay for the study of cyclic nucleotide binding to proteins. Methods Enzymol. 159:147.
31. Hasler, P., J. J. Moore, and G. M. Kammer. 1992. Human T lymphocyte cAMP-dependent protein kinase: subcellular distributions and activity ranges of type I and type II isozymes. FASEB J. 6:2735.
32. Sugden, P. H., and J. D. Corbin. 1976. Adenosine 3′:5′-cyclic monophosphate-binding proteins in bovine and rat tissues. Biochem. J. 159:423.
33. Laxminarayana, D., A. Berrada, and G. M. Kammer. 1993. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J. Clin. Invest. 92:2207.
34. Woodford, T. A., L. A. Correll, G. S. McKnight, and J. D. Corbin. 1989. Expression and characterization of mutant forms of the type I regulatory subunit of cAMP-dependent protein kinase. J. Biol. Chem. 264:13321.
35. Kemp, B. E., R. B. Pearson, and C. M. House. 1991. Pseudosubstrate-based peptide inhibitors. Methods Enzymol. 201:287.
36. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
37. Gallagher, S. 1995. One dimensional gel electrophoresis of proteins. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and K. Struhl, eds. John Wiley and Sons, p. 10.2.30.
38. Bennett, J. P., Jr., and H. I. Yamamura. 1985. Neurotransmitter, Hormone, or Drug Receptor Binding Methods. In Neurotransmitter Receptor Binding, 2nd Ed. H. I. Yamamura, ed. Raven Press, New York, p. 61.
39. 3-cAMP. FEBS Lett. 150:161.
40. Inghirami, G., J. Simon, J. E. Balow, and G. C. Tsokos. 1988. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clin. Exp. Rheumatol. 6:269.
41. Flockhart, D. A., and J. D. Corbin. 1982. Regulatory mechanisms in the control of protein kinases. CRC Crit. Rev. Biochem. 12:133.
42. Skålhegg, B. S., B. Landmark, K. B. Foss, S. M. Lohmann, V. Hansson, T. Lea, and T. Jahnsen. 1992. Identification, purification and characterization of subunits of cAMP-dependent protein kinase in human testis. J. Biol. Chem. 267:5374.
43. Zick, S. K., and S. S. Taylor. 1982. Interchain disulfide bonding in the regulatory subunit of cAMP-dependent protein kinase I. J. Biol. Chem. 257:2287.
44. Taylor, S. S., J. Bubis, J. Toner-Webb, L. D. Saraswat, E. A. First, J. A. Buechler, D. R. Knighton, and J. Sowadski. 1988. cAMP-dependent protein kinase: prototype for a family of enzymes. FASEB J. 2:2677.
45. Døskeland, S. O. 1978. Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3′:5′-cyclic monophosphate. Biochem. Biophys. Res. Commun. 83:542.
46. Rannels, S. R., and J. D. Corbin. 1980. Two different intrachain cAMP binding sites of cAMP-dependent protein kinases. J. Biol. Chem. 255:7085.
47. Herberg, F. W., W. R. G. Dostmann, M. Zorn, S. J. Davis, and S. S. Taylor. 1994. Crosstalk between domains in the regulatory subunit of cAMP-dependent protein kinase: Influence of amino terminus on cAMP binding and holoenzyme formation. Biochemistry 33:7485.
48. Friedrich, U., and P. Coffino. 1977. Mutagenesis in S49 mouse lymphoma cells: induction of resistance to ouabain, 6-thioguanine, and dibutyryl cyclic AMP. Proc. Natl. Acad. Sci. USA 74:679.
49. Steinberg, R. A., P. H. O'Farrell, U. Friedrich, and P. Coffino. 1977. Mutations causing charge alterations in regulatory subunits of the cAMP-dependent protein kinase of cultured S49 lymphoma cells. Cell 10:381.
50. Bourne, H. R., P. Coffino, and G. M. Tomkins. 1974. Somatic genetic analysis of cyclic AMP action: characterization of unresponsive mutants. J. Cell. Physiol. 85:611.
51. Daniel, V., G. Litwack, and G. M. Tomkins. 1973. Induction of cytolysis of cultured lymphoma cells by adenosine 3′:5′-cyclic monophosphate and the isolation of resistant variants. Proc. Natl. Acad. Sci. USA 70:76.
52. Daniel, V., H. R. Bourne, and G. M. Tomkins. 1973. Altered metabolism and endogenous cyclic AMP in cultured cells deficient in cyclic AMP binding proteins. Nature 244:167.
53. Steinberg, R. A. 1984. Fine-structure mapping of charge-shift mutations in regulatory subunit of type I cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 4:1086.
54. Murphy, C. S., and R. A. Steinberg. 1985. Hot spots for spontaneous and mutagen-induced lesions in regulatory subunit of cyclic AMP-dependent protein kinase in S49 mouse lymphoma cells. Somat. Cell Mol. Genet. 11:605.
55. Steinberg, R. A., K. B. Gorman, D. Øgreid, S. O. Døskeland, and I. T. Weber. 1991. Mutations that alter the charge of type I regulatory subunit and modify activation properties of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells. J. Biol. Chem. 266:3547.
56. Steinberg, R. A., J. L. Russell, C. S. Murphy, and D. A. Yphantis. 1987. Activation of type I cyclic AMP-dependent protein kinases with defective cyclic AMP-binding sites. J. Biol. Chem. 262:2664.
57. Correll, L. A., T. A. Woodford, J. D. Corbin, P. L. Mellon, and G. S. McKnight. 1989. Functional characterization of cAMP-binding mutations in type I protein kinase. J. Biol. Chem. 264:16672.
58. Bubis, J., J. J. Neitzel, L. D. Saraswat, and S. S. Taylor. 1988. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase. J. Biol. Chem. 263:9668.
59. Clegg, C. H., L. A. Correl, G. G. Cadd, and G. S. McKnight. 1987. Inhibition of intracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit. J. Biol. Chem. 262:13111.
60. Steinberg, R. A., T. van Daalen Wetters, and P. Coffino. 1978 Kinase-negative mutants of S49 mouse lymphoma cells carry a trans-dominant mutation affecting expression of cAMP-dependent protein kinase. Cell 15:1351.
61. Laxminarayana, D., and G. M. Kammer. 1996. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation. J. Immunol. 156: 497.
62. Kammer, G. M., C. A. Boehm, S. A. Rudolph, and L. A. Schultz. 1988. Mobility of the human T lymphocyte surface molecules CD3, CD4 and CD8: regulation by a cAMP-dependent pathway. Proc. Natl. Acad. Sci. USA 85:792.
63. Yamamoto, K. K., G. A. Gonzalez, W. H. Biggs III, and M. R. Montminy. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494.
64. Meinkoth, J. L., A. S. Alberts, W. Went, D. Fantozzi, S. S. Taylor, M. Hagiwara, M. Montminy, and J. R. Feramisco. 1993. Signal transduction through the cAMP-dependent protein kinase. Mol. Cell. Biochem. 127-128:179.